Ketovib 2% Cream contains Ketoconazole 2% w/w, an imidazole antifungal agent effective against a broad spectrum of dermatophytes, yeasts, and fungi responsible for superficial mycotic infections. It is indicated for the topical treatment of various fungal skin infections including tinea corporis, tinea cruris, tinea pedis, and pityriasis versicolor, as well as seborrheic dermatitis. Ketoconazole exerts its antifungal activity by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to cell death. Ketovib 2% Cream is applied once or twice daily to the affected area after cleansing and drying the skin, with the duration of therapy depending on the type and severity of the infection, typically ranging from 2 to 4 weeks. It is generally well tolerated, with mild local adverse effects such as burning, itching, or irritation occasionally reported. Use of Ketovib 2% Cream should be avoided in patients with known hypersensitivity to ketoconazole or any excipients. As a topical formulation, systemic absorption is minimal, reducing the risk of systemic side effects. Patients are advised to complete the full course of treatment to prevent recurrence and resistance.